Financhill
Buy
77

CDNA Quote, Financials, Valuation and Earnings

Last price:
$18.92
Seasonality move :
-9.34%
Day range:
$18.36 - $19.00
52-week range:
$10.96 - $25.95
Dividend yield:
0%
P/E ratio:
15.54x
P/S ratio:
2.87x
P/B ratio:
3.06x
Volume:
639.1K
Avg. volume:
1M
1-year change:
-24.52%
Market cap:
$953M
Revenue:
$333.8M
EPS (TTM):
$1.19

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CDNA
CareDx, Inc.
 $95.3M $0.14 18.48% -84.95% $22.33
CATX
Perspective Therapeutics, Inc.
 $206.8K -$0.32 -9.65% -37.91% $12.3077
CODX
Co-Diagnostics, Inc.
 $300K -$0.19 -15.61% -64.04% $1.50
ELMD
Electromed, Inc.
 $16.6M -- 11.04% -- $36.00
VNRX
VolitionRX Ltd.
 $806.3K -$0.04 272.5% -33.67% $2.60
XTNT
Xtant Medical Holdings, Inc.
 $28.5M -- 2.34% -100% $1.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CDNA
CareDx, Inc.
 $18.53 $22.33 $953M 15.54x $0.00 0% 2.87x
CATX
Perspective Therapeutics, Inc.
 $2.4000 $12.3077 $178.4M -- $0.00 0% 162.73x
CODX
Co-Diagnostics, Inc.
 $0.37 $1.50 $22.8M -- $0.00 0% 25.09x
ELMD
Electromed, Inc.
 $27.81 $36.00 $231.9M 29.92x $0.00 0% 3.71x
VNRX
VolitionRX Ltd.
 $0.30 $2.60 $36.8M -- $0.00 0% 20.54x
XTNT
Xtant Medical Holdings, Inc.
 $0.62 $1.50 $86.2M 60.39x $0.00 0% 0.67x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CDNA
CareDx, Inc.
 8.16% 2.039 3.7% 2.44x
CATX
Perspective Therapeutics, Inc.
 1.35% 3.691 1.3% 8.47x
CODX
Co-Diagnostics, Inc.
 3.56% 2.894 8.89% 3.13x
ELMD
Electromed, Inc.
 -- 1.217 -- 4.58x
VNRX
VolitionRX Ltd.
 -48.16% 2.566 15.4% 0.04x
XTNT
Xtant Medical Holdings, Inc.
 39.2% 2.955 35.76% 1.08x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CDNA
CareDx, Inc.
 $68.7M $2M 19.41% 21.1% 2.01% $35.4M
CATX
Perspective Therapeutics, Inc.
 -$566K -$27.9M -37.13% -37.63% -13330.62% -$18.3M
CODX
Co-Diagnostics, Inc.
 -$148.3K -$7M -62.71% -65.15% -4823.8% -$6M
ELMD
Electromed, Inc.
 $13.2M $2.7M 18.88% 18.89% 15.81% -$98K
VNRX
VolitionRX Ltd.
 $318.2K -$5.1M -- -- -813.17% -$3.5M
XTNT
Xtant Medical Holdings, Inc.
 $22M $2.5M 2.15% 3.78% 7.64% $4.2M

CareDx, Inc. vs. Competitors

  • Which has Higher Returns CDNA or CATX?

    Perspective Therapeutics, Inc. has a net margin of 1.67% compared to CareDx, Inc.'s net margin of -12425.36%. CareDx, Inc.'s return on equity of 21.1% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.

    Company Gross Margin Earnings Per Share Invested Capital
    CDNA
    CareDx, Inc.
    		 68.71% $0.03 $338.8M
    CATX
    Perspective Therapeutics, Inc.
    		 -270.81% -$0.35 $245.5M
  • What do Analysts Say About CDNA or CATX?

    CareDx, Inc. has a consensus price target of $22.33, signalling upside risk potential of 20.53%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 412.82%. Given that Perspective Therapeutics, Inc. has higher upside potential than CareDx, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than CareDx, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CDNA
    CareDx, Inc.
    		 4 4 0
    CATX
    Perspective Therapeutics, Inc.
    		 12 1 0
  • Is CDNA or CATX More Risky?

    CareDx, Inc. has a beta of 2.544, which suggesting that the stock is 154.38% more volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.

  • Which is a Better Dividend Stock CDNA or CATX?

    CareDx, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CareDx, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CDNA or CATX?

    CareDx, Inc. quarterly revenues are $100.1M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. CareDx, Inc.'s net income of $1.7M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, CareDx, Inc.'s price-to-earnings ratio is 15.54x while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CareDx, Inc. is 2.87x versus 162.73x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CDNA
    CareDx, Inc.
    		 2.87x 15.54x $100.1M $1.7M
    CATX
    Perspective Therapeutics, Inc.
    		 162.73x -- $209K -$26M
  • Which has Higher Returns CDNA or CODX?

    Co-Diagnostics, Inc. has a net margin of 1.67% compared to CareDx, Inc.'s net margin of -4048.69%. CareDx, Inc.'s return on equity of 21.1% beat Co-Diagnostics, Inc.'s return on equity of -65.15%.

    Company Gross Margin Earnings Per Share Invested Capital
    CDNA
    CareDx, Inc.
    		 68.71% $0.03 $338.8M
    CODX
    Co-Diagnostics, Inc.
    		 -102% -$0.16 $41.3M
  • What do Analysts Say About CDNA or CODX?

    CareDx, Inc. has a consensus price target of $22.33, signalling upside risk potential of 20.53%. On the other hand Co-Diagnostics, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 300.53%. Given that Co-Diagnostics, Inc. has higher upside potential than CareDx, Inc., analysts believe Co-Diagnostics, Inc. is more attractive than CareDx, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CDNA
    CareDx, Inc.
    		 4 4 0
    CODX
    Co-Diagnostics, Inc.
    		 0 1 0
  • Is CDNA or CODX More Risky?

    CareDx, Inc. has a beta of 2.544, which suggesting that the stock is 154.38% more volatile than S&P 500. In comparison Co-Diagnostics, Inc. has a beta of 1.149, suggesting its more volatile than the S&P 500 by 14.942%.

  • Which is a Better Dividend Stock CDNA or CODX?

    CareDx, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Co-Diagnostics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CareDx, Inc. pays -- of its earnings as a dividend. Co-Diagnostics, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CDNA or CODX?

    CareDx, Inc. quarterly revenues are $100.1M, which are larger than Co-Diagnostics, Inc. quarterly revenues of $145.4K. CareDx, Inc.'s net income of $1.7M is higher than Co-Diagnostics, Inc.'s net income of -$5.9M. Notably, CareDx, Inc.'s price-to-earnings ratio is 15.54x while Co-Diagnostics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CareDx, Inc. is 2.87x versus 25.09x for Co-Diagnostics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CDNA
    CareDx, Inc.
    		 2.87x 15.54x $100.1M $1.7M
    CODX
    Co-Diagnostics, Inc.
    		 25.09x -- $145.4K -$5.9M
  • Which has Higher Returns CDNA or ELMD?

    Electromed, Inc. has a net margin of 1.67% compared to CareDx, Inc.'s net margin of 12.65%. CareDx, Inc.'s return on equity of 21.1% beat Electromed, Inc.'s return on equity of 18.89%.

    Company Gross Margin Earnings Per Share Invested Capital
    CDNA
    CareDx, Inc.
    		 68.71% $0.03 $338.8M
    ELMD
    Electromed, Inc.
    		 78.15% $0.25 $44.7M
  • What do Analysts Say About CDNA or ELMD?

    CareDx, Inc. has a consensus price target of $22.33, signalling upside risk potential of 20.53%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 29.45%. Given that Electromed, Inc. has higher upside potential than CareDx, Inc., analysts believe Electromed, Inc. is more attractive than CareDx, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CDNA
    CareDx, Inc.
    		 4 4 0
    ELMD
    Electromed, Inc.
    		 4 0 0
  • Is CDNA or ELMD More Risky?

    CareDx, Inc. has a beta of 2.544, which suggesting that the stock is 154.38% more volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.259, suggesting its less volatile than the S&P 500 by 74.113%.

  • Which is a Better Dividend Stock CDNA or ELMD?

    CareDx, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CareDx, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CDNA or ELMD?

    CareDx, Inc. quarterly revenues are $100.1M, which are larger than Electromed, Inc. quarterly revenues of $16.9M. CareDx, Inc.'s net income of $1.7M is lower than Electromed, Inc.'s net income of $2.1M. Notably, CareDx, Inc.'s price-to-earnings ratio is 15.54x while Electromed, Inc.'s PE ratio is 29.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CareDx, Inc. is 2.87x versus 3.71x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CDNA
    CareDx, Inc.
    		 2.87x 15.54x $100.1M $1.7M
    ELMD
    Electromed, Inc.
    		 3.71x 29.92x $16.9M $2.1M
  • Which has Higher Returns CDNA or VNRX?

    VolitionRX Ltd. has a net margin of 1.67% compared to CareDx, Inc.'s net margin of -862.39%. CareDx, Inc.'s return on equity of 21.1% beat VolitionRX Ltd.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CDNA
    CareDx, Inc.
    		 68.71% $0.03 $338.8M
    VNRX
    VolitionRX Ltd.
    		 50.73% -$0.05 -$24.7M
  • What do Analysts Say About CDNA or VNRX?

    CareDx, Inc. has a consensus price target of $22.33, signalling upside risk potential of 20.53%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.60 which suggests that it could grow by 767.53%. Given that VolitionRX Ltd. has higher upside potential than CareDx, Inc., analysts believe VolitionRX Ltd. is more attractive than CareDx, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CDNA
    CareDx, Inc.
    		 4 4 0
    VNRX
    VolitionRX Ltd.
    		 4 2 0
  • Is CDNA or VNRX More Risky?

    CareDx, Inc. has a beta of 2.544, which suggesting that the stock is 154.38% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

  • Which is a Better Dividend Stock CDNA or VNRX?

    CareDx, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CareDx, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CDNA or VNRX?

    CareDx, Inc. quarterly revenues are $100.1M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. CareDx, Inc.'s net income of $1.7M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, CareDx, Inc.'s price-to-earnings ratio is 15.54x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CareDx, Inc. is 2.87x versus 20.54x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CDNA
    CareDx, Inc.
    		 2.87x 15.54x $100.1M $1.7M
    VNRX
    VolitionRX Ltd.
    		 20.54x -- $627.3K -$5.4M
  • Which has Higher Returns CDNA or XTNT?

    Xtant Medical Holdings, Inc. has a net margin of 1.67% compared to CareDx, Inc.'s net margin of 3.93%. CareDx, Inc.'s return on equity of 21.1% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

    Company Gross Margin Earnings Per Share Invested Capital
    CDNA
    CareDx, Inc.
    		 68.71% $0.03 $338.8M
    XTNT
    Xtant Medical Holdings, Inc.
    		 66.13% $0.01 $82.9M
  • What do Analysts Say About CDNA or XTNT?

    CareDx, Inc. has a consensus price target of $22.33, signalling upside risk potential of 20.53%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 143.51%. Given that Xtant Medical Holdings, Inc. has higher upside potential than CareDx, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than CareDx, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CDNA
    CareDx, Inc.
    		 4 4 0
    XTNT
    Xtant Medical Holdings, Inc.
    		 2 0 0
  • Is CDNA or XTNT More Risky?

    CareDx, Inc. has a beta of 2.544, which suggesting that the stock is 154.38% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

  • Which is a Better Dividend Stock CDNA or XTNT?

    CareDx, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CareDx, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CDNA or XTNT?

    CareDx, Inc. quarterly revenues are $100.1M, which are larger than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. CareDx, Inc.'s net income of $1.7M is higher than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, CareDx, Inc.'s price-to-earnings ratio is 15.54x while Xtant Medical Holdings, Inc.'s PE ratio is 60.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CareDx, Inc. is 2.87x versus 0.67x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CDNA
    CareDx, Inc.
    		 2.87x 15.54x $100.1M $1.7M
    XTNT
    Xtant Medical Holdings, Inc.
    		 0.67x 60.39x $33.3M $1.3M

Related Companies

Get CDNA Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

CDNA
Sector
P/E ratio
15.54x
23.75x
PEG ratio
-0.13x
-0.01x
P/B ratio
3.06x
1.83x
Price / LTM sales
2.87x
1.60x

Growth Metrics

CDNA
Sector
Revenue growth
20.72%
4.85%
Earnings growth
115.52%
11.11%
Revenue (5-year growth)
21.31%
6.45%
Earnings forecast
$0.14
-$0.20

Profitability

CDNA
Sector
Profitability FY 2024
$221.6M
$3.6M
Return on invested capital
19.41%
-30.98%
Return on assets
15%
-27.62%
Return on equity
21.1%
-36.69%

Earnings Date

Last Earnings Date
Nov
4
Next Earnings Date
Mar
2
Estimated Next Earnings Date
Feb
3

Balance Sheet

CDNA
Sector
Total cash
$194.2M
$27.2M
Short term investments
$146M
$25.7M
Total assets
$505.5M
$79.7M
Long term debt
$21.2M
$4.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Read article
Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Read article
Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Read article

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy or Sell?
Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy or Sell?
Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy or Sell?

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy or Sell?
Buy
72
KYMR alert for Dec 8

Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.

Buy or Sell?
Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.

Buy or Sell?
Master Safe Stock Market Strategies
Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

Stocks by Sector